1[1]Lopez-Castilla J, Diaz-Fernandez F, Soult JA, et al. Primary leptomeningeal melanoma in a child [J]. Pediatr Neurol, 2001;24(5): 390-392.
2[2]Greco-Crasto S, Soffietti R, Bradac GB, et al. Primitive cerebral melanoma: case report and review of the literature [J]. Surg Neurol, 2001; 55(3): 163-168.
3[3]Salpietro FM, Alafaci C, Gervasio O, et al. Primary cervical melanoma with brain metastases. Case report and review of the literature [J]. J Neurosurg, 1998; 89(4): 659-666.
4[4]Lang PG. Current concepts in the management of patients with melanoma [J]. Am J Clin Dermatol, 2002; 3(6):401-426.
5[5]Hoon DS, Kuo CT, Wascher RA, Fournier P, et al. Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients [J]. J Invest Dermatol, 2001; 117(2): 375-378.
6[6]Hau P, Apfel R, Wiese P, et al. Melanoma-inhibiting activity(MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin [J]. Anticancer Res, 2002;22(2A): 577-583.
7[7]Mingione V, Oliveira M, Prasad D, et al. Gamma surgery for melanoma metastases in the brain [J]. J Neurosurg, 2002; 96(3): 544-551.
8[8]Douglas JG, Margolin K. The treatment of brain metastases from malignant melanoma [J]. Semin Oncol, 2002; 29(5):518-524.
9[9]Margolin K, Atkins B, Thompson A, et al. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase Ⅱ trial of the Cytokine Working Group [J]. J Cancer Res Clin Oncol, 2002; 128(4): 214-218.
10[10]Atkins MB, Gollob JA, Sosman JA, et al. A phase Ⅱ pilot trial of concurrent biochemotherapy with cisplatin, vinblastine,temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma [J]. Clin Cancer Res, 2002; 8(10):3075-3081.
